Funding for this research was provided by:
Natural Science Foundation of Shaanxi Province (2017SF-196)
National Natural Science Foundation of China (81771705)
Article History
Received: 12 October 2022
Accepted: 2 May 2023
First Online: 8 May 2023
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Xijing Hospital Ethics Committee (KY20173178-1). Patient consent was waived by Wuhan Servicebio technology since the study does not involve any further health risks or cause the patients any further harm and obtaining informed consent was estimated as disproportionately difficult.
: Not applicable.
: The authors declare that they have no competing interests.